RxDoctor Payments Data

Richard Neel, MD

Emergency Medicine · Castroville, TXNPI 1508986217

Payments from drug & device makers

$704in general payments, 2019–2025

Across 28 payments — averaging $25.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$269
  • AbbVie$131
  • Biohaven Pharmaceutical Holding Company Ltd.$116
  • Genentech USA, Inc.$89
  • Exact Sciences$19
  • AstraZeneca$19
  • plus $62 from 4 others

What the payments were for

  • Speaking & faculty fees$15021%
  • Food & beverage$55479%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$704 in reported general payments places this provider in the 90th percentile of 3,952 emergency medicine providers in Texas.

See all emergency medicine providers in Texas

Medicare billing

Part B allowed, 2024
$72,309
Medicare patients
394
Services billed
1,534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$10,131
ArexvyRsvpref3 Antigen/As01e/Pf20$5,857
ShingrixVaricella-Zoster Ge/As01b/Pf17$3,685
Azelastine Hcl56$850
Albuterol Sulfate HfaAlbuterol Sulfate29$536
Azithromycin122$485
Cefdinir30$399
Celecoxib22$380
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav35$375
Oseltamivir Phosphate13$283
CefuroximeCefuroxime Axetil29$278
Montelukast Sodium22$265
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst16$228
Losartan Potassium13$181
Doxycycline Hyclate12$168

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$10,13118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,952 emergency medicine providers in Texas.

Other emergency medicine in Castroville

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →